Market View
J200 114,217.00 +0.35% J203 122,213.00 +0.38% J210 143,348.00 -0.12% J211 131,686.00 +0.66% J212 26,627.00 +0.77% J213 144,924.00 +0.70%
Winning Shares (Top 5)
Code Name Added Price Latest % Gain % Gain/Year
SUR SPURCORP 2023-08-08 2488 3780 +51.93% +20.62%
ADH ADVTECH 2023-08-14 1975 3979 +101.47% +40.57%
CGR CALGRO-M3 2023-08-15 356 535 +50.28% +20.12%
CAA CA-SALES 2023-08-25 775 1500 +93.55% +37.85%
CPI CAPITEC 2023-11-04 185496 467328 +151.93% +66.73%
Opinions (Top 5)
Code Name Date Action
AEL ALTRON-A 2026-02-13 View

Allied Electronics Corp, or Altron (AEL), is an information and communications technology company which was started by Bill Venter in 1965. It has recently been re-focusing on its core business and has sold its 80% stake in Powertech and its 100% subsidiary, Altech UEC (a developer of set-top boxes).

Powertech was also sold to a BEE consortium. Altron is in the process of selling CBI Telecom Cables. Altron operates in six African countries as well as the UK and Australia. The company said it had "...secured key wins in both the public and the private sector...", including the Gauteng Broad Band Network phase 2 contract and FNB's data and analytics contract.

Netstar won the eThekwini 3-year contract for vehicle tracking for 7000 vehicles. Bytes, in the UK, which has now been unbundled and separately listed both in the UK and in an inward listing on the JSE, won a 5-year contract for Windows 10 from the NHS (UK). Altech aims to re-structure its debt to reduce its interest bill and has resumed paying dividends.

They acquired Phoenix Software in the UK for R698m. On 17th December 2020, the company announced the successful listing of its subsidiary Bytes Technology on the London Stock Exchange (LSE) at a price of GBP2.70. In its results for the six months to 31st August 2025 the company reported down 4% and headline earnings per share (HEPS) up 18%.

The company said, "Continuing operations(1) earnings before interest, tax, depreciation and amortisation ("EBITDA") of R938 million, up 4%. Group EBITDA up 2% to R905 million. Continuing operations(1) operating profit of R549 million, up 15%, positively impacted by the change in depreciation policy in Netstar.

Group operating profit up 11% to R516 million". In a trading statement for the year to 28th February 2026 the company estimated that HEPS would increase by at least 50%. Technically, the share was in a strong rising trend, but that came to an end with a "double top" in January and May 2025.

Since then it has been falling. The latest results have caused the share price to jump up - so maybe a new upward trend is now in place.

S32 SOUTH32 2026-02-13 View

South 32 (S32) was spun out of BHP Billiton in 2015 and contained all of BHP's South African coal assets. It is, in its own right, a diversified miner of base metals and minerals such as zinc, coal, aluminium, silver, lead, nickel and manganese. It operates in South Africa, South America and Australia.

The company has separated out its coal assets in South Africa and especially those which supply Eskom, into a separate entity which was sold on 1st June 2020 to Seriti. At the same time the company has announced that it has bought the remaining 83% of Arizona Mining which it did not already own.

Arizona Mining has extensive interests in zinc, manganese and silver described by South 32's CEO, Graham Kerr, as "...one of the most exciting base metal projects in the world." Clearly, this is another international mining house that is distancing itself from South Africa because of the administrative and legislative uncertainty here. Kerr has stated that "...mining exploration is out of the question in South Africa until the new mining charter is finalised." In moving away from South African investments, South 32 is following in the footsteps of BHP and Anglo.

In our view, South32 is an excellent mining conglomerate with good medium-term potential to exploit the recovery in base metals and minerals. The company has said that for the moment it plans to hold onto its South Deep mine. The company is continuing with its $1,4bn share buy-back.

The company is working to supply its Hillside smelter with renewable energy and transition away from Eskom over the next 10 years. In its results for the six months to 31st December 2025 the company reported revenue down 3% and headline earnings per share (HEPS) of 9c (US) compared with 8,5c in the previous period.

The company said, ""We delivered Underlying EBITDA of US$1.1B and 16 per cent growth in Underlying earnings to US$435M". Technically, the share has been in an upward trend since September 2025. We expect this trend to continue, but it remains a volatile commodity share. On 12th May 2025 the company announced that Matthew Daley would join the company as deputy CEO with effect from 2nd February 2026 to succeed Graham Kerr when he retires later in 2026.

ANH AB-INBEV 2026-02-13 View

Anheuser-Busch, or AB-InBev (ANH), is the world's largest brewer of beer, operating in both first world countries and emerging markets. ANH trades on the JSE as ANH, the Brussels Stock Exchange as ABI and the New York Stock Exchange (NYSE) as BUD. It announced its intention to list its Asia-Pacific arm on the Hong Kong stock exchange to raise approximately $10bn.

The cash will be used to reduce its debt. The company has brands like Budweiser, Stella Artois, Castle, Becks and Corona. After the acquisition of SA Breweries, AB InBev is four times the size of the world's next largest brewer - Heineken - so there is very limited potential for further meaningful acquisitions.

Growth from here on must be organic. Because of its American exposure, the company reports quarterly.  In its results for the six months to 30th June 2025 the company reported revenue up 3% and underlying profit of $1950m. Volumes fell by 1,9% with beer volumes down 2,2%. Headline earnings per share (HEPS) were 1,95c (US) compared with 1,33c in the previous period.

In an update for the 3rd quarter ending on 30th September 2025 the company reported revenue up 0,9% and volumes down 3,7%. The company said, "Reported profit attributable to equity holders of AB InBev was 1 054 million USD in 3Q25 compared to 2 071 million USD in 3Q24. On a constant currency basis, Underlying EPS increased by 0.3% in 3Q25 and by 11.8% in 9M25".

In an update on the 4th quarter of 2025 the company reported revenue up 2,5% and underlying earnings per share (EPS) up 6%. There was free cash flow generation of $11,3bn. Volumes were down 1,5% in 4Q and 2,3% for the year. From a private investor's perspective, this is a massive international blue chip share which is clearly a good rand-hedge.

At current levels it is trading on a P:E of 18,91 - which still looks fairly fully priced to us. Technically, it was in a downward trend from when it listed on the JSE and we recommended waiting until it broke up through its long-term downward trendline. That happened on 4th November 2022 at 94065c.

It has since moved up to 127363c.

UPL UPARTNERS 2026-02-12 View

Universal Partners (UPL) is an investment holding company with a primary listing in Mauritius and a secondary listing on the Alt-X of the JSE. It listed in 2013 and has made five investments: (1) Dentex Healthcare Group, which owns 56 dental practices in the UK; (2) Yasa, a distributor of controllers for high power density electric motors.

This company was sold to Mercedes Benz for GBP42,8m. (3) SC Lowy, a market-maker in distressed and high-yield debt especially in Asia; (4) Propelair, a supplier of water-efficient toilets in the UK; (5) JSA Services, a provider of personal service companies, payroll and umbrella services to temporary workers in the UK.

In its results for the six months to 31st December 2025 the company reported net asset value (NAV) at 2609c (ZAR) - down from the 2816c reported a year ago. The headline loss per share was 1,19 pence compared with a loss of 9,58 pence in the previous period. This share is far too thinly traded to be of interest to private investors.

APN ASPEN 2026-02-12 View

Aspen (APN) is a pharmaceutical company which trades in 150 countries in a wide range of specialty and branded products aimed at a range of acute and chronic medical conditions. They have 25 manufacturing facilities on 15 sites. Their main product categories are thrombosis, anaesthetics, cytotoxics and nutritionals.

Pharmaceuticals generally are a defensive industry which does well even during a recession because people are compelled to buy chronic medications. However, a major factor in Aspen's case is the strength of the rand. In the longer term, the company expects that its interests in China will eventually be larger than its South African interests.

The company's business is now "heavily weighted" towards emerging markets. In its results for the year to 30th June 2025 the company reported revenue down 3% and headline earnings per share (HEPS) down 42%. The company said, "Commercial Pharmaceuticals, Aspen's core business segment comprising more than 70% of the Group's revenue, has delivered revenue and normalised EBITDA growth of 10% in constant exchange rate ("CER") underpinned by organic revenue growth in all three segments (Injectables, OTC and Prescription)." In a trading statement for the six months to 31st December 2025 the company estimated that HEPS would fall by between 33% and 38%.  The company's P:E ratio of 13,77 is not demanding for a solid, international, blue-chip, rand-hedge share like this.

On 22nd April 2025 the company warned that an industrial dispute about vaccines that it was involved in could reduce earnings before interest, taxation, depreciation and amortisation (EBITDA) by as much as R2bn. The next day (23-4-25) the share fell 30%. 

Winning Share: CAA
Opinion: APN
Datatec  (2026-02-09)

Many private investors shy away from IT shares because they can be difficult to understand. Their business models are often highly complex making it problematic to accurately assess their fundamental risk. Datatec is an international IT and telecommunications company with operations in more than 50…

Many private investors shy away from IT shares because they can be difficult to understand.  Their business models are often highly complex making it problematic to accurately assess their fundamental risk. Datatec is an international IT and telecommunications company with operations in more than 50 countries world-wide which makes it even more challenging as an investment. My response to this type of complexity is to look at the results and the people involved.

In its results for the six months to 31st August 2025 the company reported gross invoiced income up 9,4% and headline earnings per share (HEPS) up 109,5%. Clearly, this company is growing its turnover while at the same time hugely improving its operational efficiency.

Because of its international footprint, Datatec offers the investor a rand-hedge. It is also obviously benefiting from the world-wide move towards artificial intelligence (AI). It makes a gross margin of 26.3% and its operating costs are coming down. By bringing down its net debt the company has reduced its finance costs by 27.1%. From an investor’s perspective this makes buying the shares far less risky. Companies with plenty of “headroom” have the cash to avoid problems and take advantage of opportunities.  

Its business is divided into three main divisions - technology distribution through Westcon International, integration and managed services through Logicalis, and consulting and financial services through Datatec Financial Services and Analysys Mason.

Consider the chart:

Datatec (DTC) : April 2023 - 6th of February 2026. Chart by ShareFriend Pro.

The chart shows that Datatec had an extended period of sideways movement between April 2023 and October 2024. Then it began to move up strongly. We added it to the Winning Shares List (WSL) 26th October 2024 at a price of 3950c, when it began showing signs of structural improvement and it has since gone up to 7781 – a gain of 97% in 15 months. We believe it will continue to perform well as AI becomes more ubiquitous.

Jens Montanana is the CEO of Datatec and has been in that position since the company listed on the JSE more than thirty years ago. His drive and energy are what taken the company up to a market capitalisation of R12bn. Montanana says that “...the growth of interconnected digital communities and increased IT complexity drove infrastructure demand in networking and cybersecurity”. Now I will be first to admit that I do not understand the implications of that statement – but I know growth and financial stability when I see it.

The rapid rise of artificial intelligence (AI) has forced businesses to implement the technology within their operations if they are to remain competitive. Datatec is riding that wave.

Obviously, this is a company which is dominated by Montanana and that does make it vulnerable to his inevitable retirement at some stage. However, we believe that Datatec has built a very solid international; presence which will continue to provide it with growth opportunities in the future whoever is in charge.

It is not one of the fastest growing shares on the JSE, but it has been a very steady performer since we added it to the WSL.

 

Clicks Oversold  (2026-01-26)

Technical analysis is the study of investor perceptions as they are reflected in the price and volume patterns of a security. It is also true that shares move in cycles which take them from being overbought to being oversold and back again. This is especially true of the blue chip shares which are…

Technical analysis is the study of investor perceptions as they are reflected in the price and volume patterns of a security. It is also true that shares move in cycles which take them from being overbought to being oversold and back again. This is especially true of the blue chip shares which are heavily traded and patronised by the big institutions (pension funds, unit trusts and insurance companies).  The fund managers who manage the institutional portfolios account for about 90% of all trades on the JSE.

In our opinion, Clicks (CLS) is a high-quality share which should be part of every private investor’s portfolio. The problem is that it is generally very popular with the big institutions who are always buying it, which tends to make it very expensive – most of the time. But there are occasions when it goes out of fashion with the fund managers for some reason and at those moments it can represent excellent value and a great buying opportunity. In our opinion, right now is just such a moment.

A few days ago on 22nd January 2026, Clicks published a trading update for the 20 weeks up to 11th January 2026. In that update it said that group turnover was up 7,4% and that pharmacy sales had gained 9%. They also commented that they had record Black Friday sales and robust customer demand for their Christmas gift range.

Consider the diagram below.

Clicks (CSL) : February 2016 - 23rd of January 2026. Chart by ShareFriend Pro.

The top chart in the diagram below shows the share price of Clicks over the last ten years. The lower chart shows the 200-day overbought/oversold (OB/OS) of Clicks over the same period.

On the OB/OS I have drawn in a -10% buy line and you can see that over the ten-year period there have been just 5 occasions (the green arrows) on which the OB/OS has fallen below -10%. Then considering the top chart you can see that, on each of those occasions, Clicks represented an excellent buying opportunity (the red circles).

On Friday last week, the Clicks OB/OS ended the week at –10,64%. And you will observe that historically it generally does not spend a great deal of time below that minus 10% buy line. Inevitably, the fund managers become aware that it is heavily over-sold and begin buying it, driving the price up again.

Of course, the fact that Clicks is heavily oversold right now does not guarantee that it will not fall further and you should always maintain a stop-loss strategy. But, if you are buying, it does give you a good indication of your probability of being right. In my estimation, the share has spent about 2% of its time over the last ten years below that -10% buy line. That means that your statistical probability of being wrong in buying it at that level is therefore extremely low.

And you will have one great satisfaction – you are not buying it at +24% - but somebody did! Otherwise, the chart would not have gone there.  It is amazing to consider that, less than 4 months ago on 25th September 2025, there were institutional fund managers buying Clicks at an OB/OS level of over +24% (the red arrow). If you buy now at -10,64%, you are certainly doing a lot better than them!

The Collapse of Choppies  (2026-01-19)

The fall in the Choppies share price from 795c on 2nd January 2026 to last Friday’s close at 290c is a great example of the volatility of markets, especially in shares which are relatively thinly traded. It demonstrates the importance of investor sentiment and the potential for popular shares to…

The fall in the Choppies share price from 795c on 2nd January 2026 to last Friday’s close at 290c is a great example of the volatility of markets, especially in shares which are relatively thinly traded. It demonstrates the importance of investor sentiment and the potential for popular shares to rapidly become over-priced once they attract the investing public’s imagination.

Choppies represents an unusual investment opportunity on the JSE, because it is a supermarket chain which is apparently highly successful in Africa outside of South Africa. This made it unique and a potential take-over prospect on the JSE. Most of the larger grocery retailers like Shoprite and Pick ‘n Pay have made an effort to establish themselves in other African countries with varying degrees of success. Those markets tend to be characterised by high levels of inflation and political instability. Choppies, on the other hand, was demonstrably successful in the rest of Africa, but found the South African market too competitive.

This made the Choppies story unique. We first recognised Choppies potential when it broke up out of an extended period of sideways movement in March last year. We added it to the Winning Shares List (WSL) on 6th March 2025 at a price of 85c and its performance was nothing short of meteoric. Eventually, by the beginning of 2026 it was trading on a price:earnings ratio (PE) of over 100. Consider the chart:

Choppies (CHP) : September 2024  - 16th of January 2026. Chart by ShareFriend Pro.

The chart shows the extraordinary climb in Choppies share price last year and then its subsequent collapse in 2026.

So, what happened? The answer to this question is that we really do not know. There have been no explanations or even comment given by the company itself in Stock Exchange News Service (SENS). There is some speculation that there was an offer from one of the other South African supermarket giants that was then abandoned, but again the company itself has said nothing.

In our view, the Choppies business proposition gained momentum leading up to the publication of its financials on 22nd September 2025 causing its share price to run up too quickly – accompanied by rising volumes. Investors felt that the company had suddenly caught the attention of institutional investors.

On 8th January 2026, probably a single investor decided to take profits and gave a market order to his broker to sell a million shares “at best”. The investor concerned was almost certainly a beneficiary of the Choppies “Long-term Investment Scheme” (LTI) and a member of the company’s senior management. The trade demonstrated his ignorance of the share market because he dumped a huge amount of shares into a relatively thinly traded market in a single day. A more experienced investor would have dribbled the shares into the market over a number of days thus giving time for the market to adjust. The problem is that 89% of the shares in issue are held by just two investors – which means that the “free float” is relatively small.  

So, how should you have handled this situation as a private investor? The answer is to strictly apply your stop-loss strategy. On the day after the share fell (Friday 9th January 2026) you should have sold out your holding on stop-loss. You would have got prices of at least 400c per share. If you bought the shares when we put them on the WSL on 6th March 2025, you would still more than quadrupled your initial investment. The lesson is never ignore your stop-loss.

And what should you do now? Well, when a share falls heavily like this, we always advise applying a 65-day exponential moving average (MA) and then waiting for the price to break up through that MA. There may still be some bad news which has not come out so you don’t want to buy prematurely. Wait for the share to settle down at these lower levels and then buy when it begins to move up again.

Notably, Choppies, at its current price (290c), is now on a P:E of 41 – which is far more attractive than its peak of over 113, but still very fully priced when compared to other grocery retailers on the JSE. Shoprite is on a PE 19.6 of and Spar is at 18,41.  

JSE Top 40

114,217.00 (+0.35%)

All Share

122,213.00 (+0.38%)

Financial 15

26,627.00 (+0.77%)

J200
J203
J212
Top Gainers
# Code Name Close (c) % move
1 LAB LABAT 8 +60.00%
2 RHB RHBOPHELO 219 +18.38%
3 BRN BRIMSTN-N 630 +16.67%
Top Losers
# Code Name Close (c) % move
1 VIS VISUAL 2 -33.33%
2 MTU MANTENGU 39 -9.30%
3 TRL TRELLIDOR 150 -8.54%

Top Movers – Charts

Top Gainer: LAB
Top Loser: VIS